138 related articles for article (PubMed ID: 6221642)
21. [Thrombocyte function and the prostacyclin-thromboxane system in patients with acute myocardial infarct].
Aliavi AL
Vrach Delo; 1988 Mar; (3):42-4. PubMed ID: 3293319
[No Abstract] [Full Text] [Related]
22. Effects of selective inhibition of thromboxane synthesis on renal function in humans.
Zipser RD
Am J Physiol; 1985 Jun; 248(6 Pt 2):F753-6. PubMed ID: 3839111
[TBL] [Abstract][Full Text] [Related]
23. [Cigarette smoking and lung metabolism--effect of cigarette smoking on blood levels of 6-keto PGF1 alpha, thromboxane B2 and lipoperoxide in healthy volunteers].
Ishihara Y; Kitamura S; Chijimatsu Y; Homma H
Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Dec; 22(12):1122-6. PubMed ID: 6549510
[No Abstract] [Full Text] [Related]
24. [Changes of platelet aggregation, serum thromboxane and prostacyclin in lung cancer and pulmonary metastatic patients following operation].
Takeda H; Kashimura Y; Takeoka T; Hashimoto M; Tanabe T
Kyobu Geka; 1984 Sep; 37(10):773-7. PubMed ID: 6389949
[No Abstract] [Full Text] [Related]
25. Implications for thromboxane A2 in the pathogenesis of endotoxic shock.
Wise WC; Cook JA; Halushka PV
Adv Shock Res; 1981; 6():83-91. PubMed ID: 6961767
[TBL] [Abstract][Full Text] [Related]
26. [Biochemistry of coronary artery disease--prostaglandins].
Tada M; Kuzuya T; Ohmori M
Rinsho Byori; 1983 Aug; 31(8):854-9. PubMed ID: 6361336
[No Abstract] [Full Text] [Related]
27. [Plasma thromboxane B2 and capacity of the aorta to produce prostacyclin in arteriopathies of the lower extremities].
Jouve R; Rolland PH; Pellegrin E; Mercier C; Delboy C; Serradimigni A
J Mal Vasc; 1983; 8(3):221-5. PubMed ID: 6355348
[TBL] [Abstract][Full Text] [Related]
28. Generation of endogenous prostaglandins and thromboxanes in taurocholate-induced gastric mucosal lesions.
Konturek SJ; Brzozowski T; Radecki T; Dobrzańska M
Scand J Gastroenterol Suppl; 1984; 92():91-6. PubMed ID: 6377475
[TBL] [Abstract][Full Text] [Related]
29. Early hemodynamic and renal effects of tumor necrosis factor alpha: role of thromboxane.
Girardin E; Grau GE; Paunier L; Le Coultre C
Circ Shock; 1994 Jan; 42(1):20-6. PubMed ID: 8149506
[TBL] [Abstract][Full Text] [Related]
30. Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models.
Ku EC; McPherson SE; Signor C; Chertock H; Cash WD
Biochem Biophys Res Commun; 1983 May; 112(3):899-906. PubMed ID: 6687803
[TBL] [Abstract][Full Text] [Related]
31. Efficiency of prostacyclin in rabbit endotoxin shock.
Ditter H; Röttger P; Voss R; Matthias FR
Prog Clin Biol Res; 1987; 236A():369-76. PubMed ID: 3303046
[No Abstract] [Full Text] [Related]
32. Use of a thromboxane synthetase inhibitor, dazoxiben, during haemodialysis.
Dodd NJ; Gordge MP; Weston MJ
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6337605
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoids do not decrease thromboxane and prostacyclin levels in human blood.
Puustinen T; Dahl ML; Uotila P; Haataja M
Prostaglandins Leukot Med; 1984 Sep; 15(3):409-10. PubMed ID: 6387721
[No Abstract] [Full Text] [Related]
34. Effects of endotoxin on hemodynamics of isolated dog kidney.
Bourgeois N; Reuse C; Boeynaems JM; Staroukine M; Vanherweghem JL
Adv Exp Med Biol; 1987; 212():81-5. PubMed ID: 3303858
[No Abstract] [Full Text] [Related]
35. Inhibition of thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1 alpha.
Pedersen AK; Watson ML; FitzGerald GA
Thromb Res; 1984 Jan; 33(1):99-103. PubMed ID: 6546456
[No Abstract] [Full Text] [Related]
36. Relationship of TXB2 and 6-keto PGF1 alpha to the hemodynamic changes during baboon endotoxic shock.
Harris RH; Zmudka M; Maddox Y; Ramwell PW; Fletcher JR
Adv Prostaglandin Thromboxane Res; 1980; 7():843-9. PubMed ID: 6768234
[No Abstract] [Full Text] [Related]
37. Plasma concentrations of thromboxane and prostacyclin metabolites in patients with bone tumors.
Mehta P; Gross S; Ostrowski N
Am J Pediatr Hematol Oncol; 1985; 7(1):88-91. PubMed ID: 2994511
[No Abstract] [Full Text] [Related]
38. Whole-blood assays for evaluation of thromboxane synthase inhibition.
Spokas EG; Nicholson NS; Suleymanov OD; Walsh GM; Tuffin D
Methods Mol Biol; 1999; 120():249-56. PubMed ID: 10343321
[No Abstract] [Full Text] [Related]
39. [The presence of 6-oxo-PGF1alpha and thromboxane B2 in peritoneal exudates released by iota-carrageenan in the rat].
Lismonde M; Deby-Dupont G; Damas J
Arch Int Physiol Biochim; 1983 Sep; 91(3):243-5. PubMed ID: 6198994
[TBL] [Abstract][Full Text] [Related]
40. Streptococcus pneumoniae-induced alterations in levels of circulating thromboxane and prostacyclin: dissociation from granulocytopenia, thrombocytopenia, and pulmonary leukostasis.
Goldblum SE; Wu KM; Tai HH
J Infect Dis; 1986 Jan; 153(1):71-7. PubMed ID: 3510262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
